...
首页> 外文期刊>Molecules >Gastroprotection of Suaveolol, Isolated from Hyptis suaveolens, against Ethanol-Induced Gastric Lesions in Wistar Rats: Role of Prostaglandins, Nitric Oxide and Sulfhydryls
【24h】

Gastroprotection of Suaveolol, Isolated from Hyptis suaveolens, against Ethanol-Induced Gastric Lesions in Wistar Rats: Role of Prostaglandins, Nitric Oxide and Sulfhydryls

机译:舒瓦洛尔,从Hyptis suaveolens分离得到的胃保护,对乙醇诱导的Wistar大鼠胃损害:前列腺素,一氧化氮和巯基的作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Hyptis suaveolens is a medicinal plant that is, according to traditional medicine, considered useful in the treatment of gastric ulcers. Although its gastroprotective activity was reported, the active compounds have not been identified. Therefore, the aim of the present study was to identify at least one active compound potentially responsible for the gastroprotective activity of H. suaveolens by using a bioassay guided study with an ethanol-induced gastric ulcer experimental model in rats. The results show that the hexane extract had protective activity (close to 70% when using doses between 10 and 100 mg/kg), and that the compound suaveolol, isolated from this extract, was one of the active gastroprotective agents. This is the first report about the gastroprotective activity of suaveolol. Rats treated with this compound at 3, 10, 30 and 100 mg/kg showed 12.6, 21.3, 39.6 and 70.2% gastroprotection respectively. The effect elicited by suaveolol (at 100 mg/kg) was attenuated by pretreatment with either NG-nitro-L-arginine methyl ester (70 mg/kg, i.p.), a nitric oxide (NO) synthase inhibitor, indomethacin (10 mg/kg, s.c.), a blocker of prostaglandin synthesis, or N-ethylmaleimide (10 mg/kg, s.c.), a blocker of sulfhydryl groups. This suggests that the gastroprotective mechanism of action of this compound involves NO, prostaglandins and sulfhydryl groups.
机译:suaveolens Hyptis是一种药用植物,根据传统医学,它被认为可用于治疗胃溃疡。尽管据报道其具有胃保护活性,但尚未鉴定出活性化合物。因此,本研究的目的是通过对大鼠乙醇诱导的胃溃疡实验模型进行生物测定指导研究,以鉴定至少一种可能对suaveolens的胃保护活性负责的活性化合物。结果表明,己烷提取物具有保护活性(当使用10至100 mg / kg剂量时接近70%),从该提取物中分离出的化合物suaveolol是一种活性的胃保护剂。这是关于舒马洛尔的胃保护活性的首次报道。用3、10、30和100 mg / kg的化合物治疗的大鼠分别具有12.6%,21.3%,39.6%和70.2%的胃保护作用。 suaveolol(100 mg / kg)引起的作用通过用N G -硝基-L-精氨酸甲酯(70 mg / kg,ip),一氧化氮(NO)预处理而减弱合酶抑制剂吲哚美辛(10 mg / kg,sc),前列腺素合成阻滞剂,或N-乙基马来酰亚胺(10 mg / kg,sc),巯基阻滞剂。这表明该化合物的胃保护作用机理涉及NO,前列腺素和巯基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号